These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1283 related articles for article (PubMed ID: 19191605)

  • 21. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
    de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of multiple surveillance modalities to assess the epidemiology of Streptococcus pneumoniae infection in Bangladesh.
    Luby SP; Brooks WA; Saha SK; el-Arifeen S; Naheed A; Sack D; Breiman RF
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S97-102. PubMed ID: 19191625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda.
    Kisakye A; Makumbi I; Nansera D; Lewis R; Braka F; Wobudeya E; Chaplain D; Nalumansi E; Mbabazi W; Gessner BD
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S153-61. PubMed ID: 19191611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001].
    Iglesias Sánchez L; Pérez-Yarza EG; García-Arenzana JM; Valiente Méndez A; Pérez-Trallero E
    An Esp Pediatr; 2002 Nov; 57(5):401-7. PubMed ID: 12467542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.
    Brooks WA; Breiman RF; Goswami D; Hossain A; Alam K; Saha SK; Nahar K; Nasrin D; Ahmed N; El Arifeen S; Naheed A; Sack DA; Luby S
    Am J Trop Med Hyg; 2007 Nov; 77(5):795-801. PubMed ID: 17984328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
    Vallès X; Flannery B; Roca A; Mandomando I; Sigaúque B; Sanz S; Schuchat A; Levine M; Soriano-Gabarró M; Alonso P
    Trop Med Int Health; 2006 Mar; 11(3):358-66. PubMed ID: 16553916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the incidence of invasive pneumococcal disease in neonates and childre aged less than 5 years in the Basque country and Navarre (Spain)].
    Bernaola Iturbe E; Aristegui Fernández Jd; Herranz Aguirre M; García Calvo C; Fernández Pérez C;
    An Esp Pediatr; 2002 Oct; 57(4):301-9. PubMed ID: 12392663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Invasive pneumococcal disease in Poland in 2010].
    Skoczyńska A; Kuch A; Gołebiewska A; Waśko I; Ronkiewicz P; Markowska M; Hryniewicz W
    Pol Merkur Lekarski; 2011 Aug; 31(182):80-5. PubMed ID: 21936342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
    Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
    Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
    Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.